Geena Malhotra appointed CTO at Torrent Pharmaceuticals, emphasizing tech-led manufacturing transformation.

Geena Malhotra is currently the Chief Technology Officer at Torrent Pharmaceuticals. This indicates that the company is striving to utilize technology to transform its medication production methods. In her role, Malhotra will create a strategy for utilizing technology. Her focus will be on applying concepts to create pharmaceuticals and manage the business. Her new position arrives as pharmaceutical firms are employing technology such as robots, data, and artificial intelligence. They aim to enhance efficiency, adhere to regulations, and produce medications.

Malhotra possesses expertise in transitioning organizations to adopt technology. She will assist Torrent Pharma in improving its drug manufacturing. This involves simplifying the process of monitoring the medicines, ensuring they are produced accurately, and confirming that everything complies with regulations.

Torrent Pharmaceuticals is a company that desires to remain in the lead. This new leader demonstrates a desire to leverage technology for improvement. The firm is utilizing technology to maintain its factories operational, monitor data in real time, and ensure that medications are produced accurately. Technology is currently essential for being quick, precise, and cost-effective.

Malhotra’s new position illustrates that technology leaders in healthcare are now more than just computer specialists. They assist in developing concepts and improving company operations. With the adoption of new technology in medicine, her leadership will guide Torrent Pharma toward producing drugs more effectively and in a contemporary manner.